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a b s t r a c t
Outer membrane blebs are naturally shed by Gram-negative bacteria and are candidates of interest for
vaccines development. Genetic modiﬁcation of bacteria to induce hyperblebbing greatly increases the
yield of blebs, called Generalized Modules for Membrane Antigens (GMMA). The composition of the
GMMA from hyperblebbing mutants of Shigella ﬂexneri 2a and Shigella sonnei were quantitatively ana-
lyzed using high-sensitivity mass spectrometry with the label-free iBAQ procedure and compared to the
composition of the solubilized cells of the GMMA-producing strains. Therewere 2306 proteins identiﬁed,
659 in GMMA and 2239 in bacteria, of which 290 (GMMA) and 1696 (bacteria) were common to both
S. ﬂexneri 2a and S. sonnei. Predicted outer membrane and periplasmic proteins constituted 95.7% and
98.7% of the protein mass of S. ﬂexneri 2a and S. sonnei GMMA, respectively. Among the remaining pro-
teins, small quantities of ribosomal proteins collectively accounted for more than half of the predicted
cytoplasmic protein impurities in the GMMA. In GMMA, the outer membrane and periplasmic proteins
were enriched 13.3-fold (S. ﬂexneri 2a) and 8.3-fold (S. sonnei) compared to their abundance in the parent
bacteria. Both periplasmic and outermembrane proteinswere enriched similarly, suggesting that GMMA
have a similar surface to volume ratio as the surface to periplasmic volume ratio in thesemutant bacteria.
Results in S. ﬂexneri 2a and S. sonnei showed high reproducibility indicating a robust GMMA-producing
process and the low contamination by cytoplasmic proteins support the use of GMMA for vaccines. Data
are available via ProteomeXch
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. Introduction
Shigellae are Gram-negative enterobacteria classiﬁed into ﬁfty
ifferent serotypes based on the carbohydrate composition of the
uter polysaccharide antigen (O antigen, OAg) of the lipopolysac-
haride (LPS) (Levine et al., 2007). The worldwide dominant
erotypes are S. sonnei and S. ﬂexneri 2a (Levine et al., 2007; Chang
t al., 2012; Livio et al., 2014). They are the etiological agent of
higellosis, one of the most frequent causes of medium and severe
iarrhea in developing countries, especially in children under ﬁve
ears of age (Kotloff et al., 2013). Currently, no Shigella vaccine is
idely available.
Gram-negative bacteria naturally shed outer membranes in a
rocess of blebbing. These particles are known as native outer
embrane vesicles (NOMV), spontaneous outer membrane vesi-
les (SOMV), or sometimes just OMV. They are quite different from
he outer membrane vesicles derived by detergent extraction of
hole bacteria (also usually called OMV or sometimes DOMV)
nd used in meningitis vaccines (Holst et al., 2013), due to the
epletion of lipoproteins and lipooligosaccharides by the detergent
rom DOMV (Ferrari et al., 2006; van de Waterbeemd et al., 2013).
he composition of NOMV reﬂects the composition of the outer
embrane of the donor bacteria, an important interface between
he bacterial cell and its environment, and thus outer membrane
lebs represent ideal candidates for vaccine development (Ellis and
uehn, 2010). Blebs present these antigens in the natural mem-
rane context and in the presence of powerful stimulators of the
nnate immune system (Ferrari et al., 2006; Park et al., 2011; Ellis
t al., 2010) and elicit protection in animal models against bacterial
nfections (Alaniz et al., 2007; Schild et al., 2008; Park et al., 2011),
ncluding Shigella (Camacho et al., 2011; Mitra et al., 2013). There-
oreNOMVhavebeenproposed for use as vaccines (Ellis andKuehn,
010). However, NOMV are generally present at low concentra-
ions in bacterial cultures. Using genetic modiﬁcation, it is possible
o induce high level shedding of blebs (“gemma” in Italian), called
eneralized Modules for Membrane Antigens (GMMA) (Berlanda
corza et al., 2012), that together with high-yield, industrial pro-
esses form the bases for a practical vaccine platform (Berlanda
corza et al., 2012; Gerke et al., 2015).
Several studies have identiﬁedproteins in the proteomeof outer
embrane blebs, e.g. from Escherichia coli (Berlanda Scorza et al.,
008),Helicobacter pylori (Mullaney et al., 2009), Edwardsiella tarda
Park et al., 2011), Francisella novicida (Pierson et al., 2011), Neisse-
ia meningitidis (van de Waterbeemd et al., 2013) and Haemophilus
nﬂuenza (Roier et al., 2015). These studies, including our previ-
us analysis of Shigella sonnei GMMA (Berlanda Scorza et al., 2012),
onducted qualitative analyses of the proteome to document the
roteins detectable. When the results were expressed by number
fproteins identiﬁed, cytoplasmicproteins that arenotpredicted to
e included in outer membrane blebs comprised a substantial pro-
ortion of the total (Berlanda Scorza et al., 2008, 2012; Choi et al.,
011). The actual proportion appears to depend on the sensitiv-
ty of the method (2D gel-based proteomics (Berlanda Scorza et al.,
008, 2012) versus LC–MS/MS (Choi et al., 2011)) and the sensitivity
f the detection. The higher the sensitivity, the more low abundant
ytoplasmicproteins aredetectedand thus the smaller thedetected
roportion of predicted periplasmic and outer membrane proteins.
Two studies used labeling techniques to quantitatively compare
he ratio of the quantity of each of the detectible proteins in two
r more related membrane samples from N. meningitidis. Chemical
sotopic labeling using heavy (CD2O) or light (CH2O) formaldehyde
as been used tomeasure the ratio of individual proteins in sponta-
eously released (SOMV), chelate induced (NOMV) and detergent
xtracted (DOMV) vesicles from an unencapsulated recombinant B
roup Neisseria meningitis carrying deletions of galE to truncate the
OS, lplX to give a penta-acyl LipidA structure and rmpM to increasedical Microbiology 306 (2016) 99–108
spontaneous OMV production (van de Waterbeemd et al., 2013).
Metabolic labeling with 15N was used in another study of unen-
capsulated N. meningitidis to quantitatively measure the relative
abundance of proteins in SOMVwith outermembranepreparations
(Lappann et al., 2013). Neither of these methods provides quantita-
tive information on the abundance of each protein present within a
single sample. For developing outer membrane vaccines, we need
to know the relativemass of eachprotein present in a single vaccine
preparation, especially for the outer membrane and periplasmic
proteins.
One study, the proteomic analysis of detergent extracted and
spontaneously releasedOMVofH. inﬂuenza (Roier et al., 2015), used
a label free technique to rank proteins within each sample on the
basis of their Mascot ion scores. While this a measure of the prob-
ability that the protein derived peptides are correctly identiﬁed it
is not a direct measure of the relative abundance.
Two studies have used label free quantiﬁcation of proteins
present in OMV to estimate the relative amount of all the proteins
detected:
• The Lappman et al. study (Lappann et al., 2013) quoted above, in
addition to using metabolic labeling to determine ratio in differ-
ent preparations, also used a non-labeled technique, normalized
spectral abundance factors (Zybailov et al., 2006) to estimate the
relative amounts of each protein within each sample.
• The abundance of proteins in spontaneously released OMV from
Pseudomonas aeruginosa (Choi et al., 2011), was measured using
the APEX tool (Lu et al., 2007).
As part of a program of developing a GMMA-based Shigella vac-
cine (Gerke et al., 2015), we used the iBAQ index (Schwanhäusser
et al., 2011) for the non-labeled, quantitative proteomic analysis of
GMMA from hyperblebbing S. sonnei 53G (Ss) and Shigella ﬂexneri
2a 2457T (Sf2a) strains and show that both preparations contain
low levels of cytoplasmic proteins, supporting the use of GMMA as
vaccines for delivering outer membrane and periplasmic antigens.
2. Materials and methods
2.1. Shigella strains and bacterial growth condition
In this study we used previously described hyperblebbing
(tolR) O antigen-deﬁcient strains of S. sonnei 53G and S. ﬂexneri
2a 2457T that were cured of the virulence plasmid: S. sonnei −p
tolR (Berlanda Scorza et al., 2012) (in this study abbreviated as
Ss) and S. ﬂexneri 2a −p tolR rfbG (Rossi et al., 2014) (in this
study abbreviated as Sf2a).
The deﬁned medium for S. sonnei was described previously
(Berlanda Scorza et al., 2012) and had the following compo-
sition: 30g/L glycerol, 2.5 g/L aspartic acid, 13.3 g/L KH2PO4,
1.2 g/L (NH4)2HPO4 4g/L, MgSO4*7H2O, 1.7 g/L citric acid, 2.5mg/L
CoCL2*6H2O, 15mg/L MnCl2*4H2O, 1.5mg/L CuCl2*2H2O, 3mg/L
H3BO3, 2.5mg/L Na2MoO4*2H2O, 13mg/L Zn(CH3COO)2*2H2O,
2M ferric citrate, 50mg/L thiamine, 10mg/L nicotinic acid. For
Sf2a, 4 g/L of glucose was also added. Both strains were grown at
37 ◦C.
2.2. Preparation of GMMA and solubilized bacteria
To produce GMMA, the strains were grown in medium supple-
mented with antibiotics (30g/mL kanamycin for Ss; 30g/mL
kanamycin and 100g/mL erythromycin for Sf2a) to OD600nm =0.3.
The cultures were then diluted into 1 L of fresh medium (without
antibiotics) to a starting OD600nm of 0.05 and incubated at 37 ◦C.
After growing to OD600nm of 0.4, in case of Ss, and of 0.3, in case
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of moles of protein present and thus iBAQi/iBAQj is the relative
molar amount of protein i. In this paper we present results as theL. Maggiore et al. / International Journa
f Sf2a, cultures were centrifuged for 15min at 5000× g and the
upernatants removed for GMMA preparation.
The bacterial pellets were solubilized after two washes with
oldphosphate buffered saline (PBS) by resuspending in lysis buffer
0.8Murea, 0.4% SDS, 1mMDTT and 20mMTris, pH 7.4) to prepare
ysates.
The culture supernatants were ﬁltered through a 0.22m ﬁl-
er unit (Millipore). The ﬁltered samples were concentrated in a
tirred Cell Model 8400 (Millipore) through a 100,000Da regener-
ted cellulose membrane (Millipore). GMMA were then separated
rom soluble proteins by ultracentrifugation at 186,000× g for 2h
t 4 ◦C (OptimaTM L-series, 45Ti rotor, Beckman Instruments). The
MMA pellets were washed once with cold PBS, resuspended in
0mM Tris, pH 7.4, then ﬁltered through a 0.22m ﬁlter.
.3. Total protein quantiﬁcation
The protein concentration in GMMA and solubilized bacte-
ia was determined using Pierce Microplate BCA Protein Assay
it-Reducing Agent Compatible (Thermo Scientiﬁc). Prior to the
etermination GMMA were diluted into the buffer used to prepare
he solubilized bacteria.
.4. SDS-PAGE
GMMA (13g) and cell lysates (26g) were mixed with
uPAGE SDS sample buffer (Invitrogen) containing 5mM Tris(2-
arboxyethyl)phosphine hydrochloride solution (TCEP, Sigma),
oiled for 10min, and iodoacetamide (IAA, Sigma) was then
dded to a ﬁnal concentration of 10mM. Following 30min incu-
ation in the dark at room temperature, the samples were loaded
nto NuPAGER 12% Bis-Tris gels using SeeBlue Plus 2 Pre-Stained
tandard (Invitrogen) for molecular weight calibration and MOPS
s running buffer (Invitrogen). Following electrophoresis, the gel
as thenﬁxedwith40%methanol (MeOH), 2%acetic acid for30min
tained overnight with Brilliant Blue G-colloidal solution (Sigma),
nd destained with 30% MeOH. Gels were scanned with an Epson
xpression 1640XL scanner.
.5. In-gel protein digestion
Each lane of the gel was excised in 15–16 slices; bands and
lank regions were excised separately. Each slice was then cut into
mall pieces and transferred into a 96-well pierced plate (Prox-
on) stacked on a normal plate. The gel pieces were destained with
0% 50mM triethylammonium bicarbonate buffer (TEAB) pH 8.0,
0% acetonitrile for 30min at 37 ◦C with shaking. The liquid was
emoved by centrifugation of the Proxeon plate. The destaining
tep was repeated until the gel pieces were completely white. The
amples were incubated with acetonitrile, the liquid was removed,
nd the plate was air-dried. The gel pieces were digested with
.15g/well of trypsin. Prior to digestion 50 fmol/well of enolase
ere added as internal standard for the label-free quantiﬁcation.
fter 2h of digestion at 37 ◦C, MeOH was added to give a ﬁnal con-
entration of 33% and another 0.15g/well of trypsin was added
o each well and the digestion was performed for additional 3h
t 37 ◦C, followed by 25 ◦C overnight. Peptides were extracted at
7 ◦C using one change of 50% acetonitrile (20min), 2 changes of
0% acetonitrile/0.25% formic acid (30min each), and one change of
ure acetonitrile (30min), dried, and stored frozen at −20 ◦C until
nalysis..6. LC/MS–MS analysis
The samples were analyzed with on-line nano LC–MS/MS
n an Ultimate 3000 RSLCnano System (Dionex) coupled to adical Microbiology 306 (2016) 99–108 101
LTQ Orbitrap Velos (Thermo Fisher) hybrid mass spectrometer
equipped with a nanospray source. Peptides were separated
on a 75m id×50 cm PepMap RSLC column (2m, Dionex)
over a 120min linear gradient of 4–32% CH3CN/0.1% FA. The
LTQ Orbitrap Velos mass spectrometer was operated in the “top
10” data-dependent acquisition mode. The 10 most abundant
multiply-charged precursor ions in the MS survey scan in the
Orbitrap (m/z 400–1500, with the lock mass at 445.120025), with a
minimal signal above 2000 counts, were dynamically selected for
Collision induced Dissociation (MS/MS) in the LTQ Velos ion trap.
The preview mode of FT master scan was disabled. The Orbitrap
resolutionwas set to 60,000 atm/z 400. The dynamic exclusionwas
set to a mass width of ±20ppm and a duration of 45 s. To achieve
high mass accuracy, the AGC (Automatic Gain Control) was set to
1×106 for the full MS survey in the Orbitrap, and to 5000 for the
MS/MS in the LTQ Velos, both with a maximum injection time of
200ms.
The raw data were analyzed by MaxQuant software, version
1.2.2.5 for both protein identiﬁcation and protein quantiﬁcation.
The Andromeda search engine was used to search the MS/MS spec-
tra using the following parameters: trypsin/P with maximum 3
missed cleavage sites; peptidemass tolerance at ﬁrst searchwas set
at 20ppm;MS/MS fragmentmass tolerance at 0.50Da, top6MS/MS
peaks per 100Da, and a minimum peptide length of 6 amino acids.
Fixed modiﬁcation for carbamidomethylation of cysteines and
variable modiﬁcations for acetylation of protein N-termini, deami-
dation of asparagines and glutamines and oxidation ofmethionines
were used. Identiﬁed peptides were searched against the avail-
able protein sequences from S. ﬂexneri (SHIFL and SHIF8 protein
databases) and S. sonnei (SHISS and SHISO databases) downloaded
from UniProt (www.uniprot.org). One identiﬁed and quantiﬁed
peptide was considered sufﬁcient to call a protein present based
on the fact that several predicted small proteins contained only 1
observable peptide. However most (2181 of 2306 proteins) were
identiﬁed on the basis of multiple peptides (Table S1). False dis-
covery rates were estimated based on the target-decoy approach
(Balgley et al., 2007) using matches to reversed sequences in a
concatenated database. The false discovery rate was set to 1%
for proteins and peptides. Protein groups with a posterior error
probability value over 0.01 or groups containing entries from the
decoy database or contaminants were discarded. Since multiple
databases were used, the software occasionally assigned homologs
into different protein groups, e.g. where one detected peptide
spanned a polymorphic region. To group genuine homologs and
identify the protein group duplications, peptide IDs for each pro-
tein were matched with the peptide ID for all other proteins.
The protein sequences of the members of the matching protein
groups were then aligned to ensure that these were indeed gen-
uine homologs and all members combined in a single protein
group.
2.7. iBAQ individual protein quantiﬁcation
Thequantity of eachproteinwas assessed as the Intensity-Based
Absolute Quantiﬁcation Index (iBAQ) (Schwanhäusser et al., 2011).
The iBAQof a protein/protein group is the sumof peak intensities of
all peptides divided by the number of theoretically observable pep-
tides. iBAQ values are approximately proportionate to the numberrelative mass of protein present (mi), calculated for each protein i
as: mi = iBAQi·Mi/(iBAQj·Mj), where Mi is the theoretical molec-
ular weight of the protein i (Ishihama et al., 2005; Schwanhäusser
et al., 2011).
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.8. Bioinformatics
Thesequencesof the identiﬁedproteinswereanalyzedbydiffer-
nt bioinformatics tools. The prediction of the sub-cellular protein
ocalization was carried out using LIPO (Berven et al., 2006) to
ook for inner and outer membrane lipoproteins. Proteins not iden-
iﬁed as lipoproteins or scored as low probability lipoproteins
ere analyzed with PSORTb v3.0 (Yu et al., 2010). Finally, pro-
eins still not assigned a deﬁnitive location were analyzed by
ignalP 4.1 (Petersen et al., 2011) using a combination of artiﬁ-
ial neural networks trained on proteins with signal peptides from
ram-negative bacteria. Proteins found to have a signal peptide
ere assumed to be periplasmic. 21 cases were manually checked,
here peptides identiﬁed by mass spectrometry matched pairs of
rthologs in the databases that had different predicted locations.
or several of these, the different databases had assumed a differ-
nt gene structure with different start codons. Where this occurred
othmembers of the pairwere assigned the same location based on
he following: if one of the pair had awell-deﬁned lipobox or signal
eptide both members of the pair were assigned to a lipoprotein
r periplasmic location, respectively. For proteins still unresolved,
he pair was assigned the location of the member with the highest
SORTb prediction score.
For proteins that were identiﬁed only in S. sonnei 53G or only
n S. ﬂexneri 2a 2457T GMMA or Lysates the theoretical presence in
he predicted proteome of the other strain was ﬁrst assessed using
rotein BLAST (National library of Medicine, http://blast.st-va.ncbi.
lm.nih.gov/Blast.cgi). If no homologous protein was identiﬁed in
he strain of interest, nucleotide BLAST of the corresponding gene
as used. In silico translation (ExPASy Bioﬁnformatics Resources
ortal, http://web.expasy.org/translate/) was used to assess if a
ucleotide BLAST hit is likely to be a functional protein coding
ene (e.g. absence of frame shifts). For positive hits, a cut-off of
0% coverage and 95% identity of the protein sequence were used
o call the protein theoretically present. The cut-off was based on
he observed variation of proteins within selected protein groups.
The mass spectrometry proteomics data have been deposited
o the ProteomeXchange Consortium (Vizcaino et al., 2014) via the
RIDE partner repository with the dataset identiﬁer PXD002517.
. Results
.1. Composition of predicted outer membrane and periplasmic
roteins in GMMA
Analysis of solubilized whole cells and GMMA from the O
ntigen- and plasmid-negative S. ﬂexneri 2a 2457T −p tolR rfbG
Sf2a Lysate and Sf2a GMMA respectively), and solubilized whole
ell and GMMA from the O antigen and plasmid-negative S. sonnei
3G −p tolR (Ss Lysate and Ss GMMA respectively) identiﬁed
306 unique protein groups (in the following referred to as pro-
eins) with an estimated abundance based on iBAQ quantiﬁcation
Table S1, listed by the protein with the highest abundance in the
rotein group). Of these proteins, 2239 were found in at least one
f the lysates, 659 of the proteins were identiﬁed in at least one
f the GMMA samples. The protein abundance in GMMA closely
ollowed the subcellular prediction made by a combination of LIPO
Berven et al., 2006), PSORTb (Yu et al., 2010), and SignalP (Petersen
t al., 2011) with 95.7% and 98.7% of the protein mass found in
he Sf2a and Ss GMMA, respectively, coming from predicted outer
embrane (including outer membrane lipoproteins, OM lipo) or
eriplasmic proteins (Table 1). Of the 659 proteins found in GMMA,
he 40 most abundant proteins account for 87.3% and 82.8% of
he protein mass in Sf2a and Ss GMMA (Table 2). Compared to
heir abundance in the corresponding lysates, most of the outerdical Microbiology 306 (2016) 99–108
membrane and periplasmic proteins are approximately 10-fold
enriched in GMMA as a proportion of total protein (Fig. 1A and B).
In accordance with the enrichment in GMMA, they comprise only
8.3% of the protein mass in Sf2a Lysates and 11.4% in Ss Lysates,
respectively.
Thenon-outermembraneandnon-periplasmicproteincategory
was dominated by similar proteins for both Sf2a and Ss GMMA.
Small quantities of ribosomal proteins collectively comprise more
than half of the mass of the cytoplasmic proteins in GMMA (Table 1
and Table S2). In addition, Tail-speciﬁc protease (E3Y2N8 SHIFL)
predicted to be located at the cytoplasmic membrane and YajG, a
putative polymerase/proteinase (Q3Z4W9 SHISS) with no deﬁni-
tive subcellular localization, are the major contributors to the
non-outer membrane/periplasmic components (Table 1).
Therewere a fewproteins that show an anomalous distribution,
expected tobeGMMAcomponents fromthepredicted locationsbut
were preferentially found in the lysate (Fig. 1 and Table S1). Pre-
dicted outer membrane lipoproteins MetQ (d-methionine-binding
lipoprotein MetQ, E7K3R2 SHISO) and CyoA (Ubiquinol oxidase,
subunit II, E7K828 SHISO), were more abundant in lysates than in
GMMA (MetQ: 0.91% and 0.82% in Sf2a and Ss Lysates vs 0.19%
and 0.07% in Sf2a and Ss GMMA, respectively; CyoA: 0.0255% in
Ss lysate vs 0.0003% in Ss GMMA). In contrast, outer membrane
predicted thiol peroxidase (E3Y2F2 SHIFL) and SpeA (Biosynthetic
arginine decarboxylase, Q3YXT3 SHISS) were only detected in Sf2a
GMMA although they were prominent in both lysates. In addition,
ten predicted periplasmic proteins were found in both the Sf2a and
Ss Lysates, but not in either of the GMMA samples (Table S1).
Proteins of speciﬁc interest in GMMA were iron-regulated outer
membrane proteins as they elicited protection in animal models
against E. coli (Fox et al., 2009), Salmonella (Kaneshige et al., 2009),
and Bordetella pertussis (Alvarez Hayes et al., 2013). Approximately
2.4% of the protein mass were comprised by iron-uptake proteins
in both Ss and Sf2a GMMA. Aerobactin siderophore receptor IutA
(E7T7F9 SHIFL), Ferrichrome-receptor FepA (E3YA60 SHIFL) and
Ferrichrome-iron receptor FhuA (E7K3K6 SHISO) were present in
both strains. CirA and iron (III) dicitrate transport protein FecA
(E7K2N5 SHISO)were additionallydetected in SsGMMA(Table S1).
In order to measure the enrichment of proteins in the GMMA
compared to the whole cell lysate, we did non-weighted linear
regressions of the log-transformed percentages of each predicted
outer membrane and periplasmic protein in GMMA versus lysate
for proteinswith amass abundance of greater than 0.01%. This gave
slopes of 0.83±0.12 and 0.85±0.09 for the Sf2a and Ss prepara-
tions, respectively. At the mid-points of the regression, there was a
predicted 13.3-fold enrichment (95% conﬁdence interval 9.1–19.5)
in Sf2a GMMA and 8.3-fold (6.5–10.7) in Ss GMMA. Neither slope
was signiﬁcantly different from 1, consistent with a similar enrich-
ment of all (across the abundance range) predicted periplasm and
outer membrane proteins in GMMA (Fig. 1). There was no statisti-
cally signiﬁcantdifference in the enrichmentofmembraneproteins
compared to periplasmic proteins in either the Sf2a or Ss prepara-
tions (p=0.94 and 0.85 by t test, for Sf2a and Ss, respectively).
3.2. Comparative analysis of Sf2a and Ss GMMA and lysates
By comparing the 4 samples, we assessed the consistency of the
samples. Of the 659 proteins identiﬁed in at least one of the GMMA
samples, 290 (44%) were common to both and these accounted for
99.6% and 94.9%, of the protein mass in Sf2a GMMA and Ss GMMA,
respectively. Similarly of the 2239 proteins identiﬁed in at least one
of the lysates, 1696 were common (76%) and these accounted for
99.0% and 96.4% of the total protein mass in the Sf2a lysate and
Ss lysate, respectively. Signiﬁcantly, the abundance of the common
proteinswashighly correlated ineachof thepairs of samples.Direct
correlation plots (Fig. 2) show that the majority of proteins lie close
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Table 1
Predicted location of proteins found in Sf2a and Ss GMMA and Lysates.
Predicted location GMMA Lysates
% mass Numberofproteins % mass Number of proteins
Sf2a Ss Sf2a Ss Sf2a Ss Sf2a Ss
Outer membrane
Outer membrane integral proteins (OM) 47.85 48.12 33 39 3.37 5.04 22 33
Outer membrane lipoprotein (OM lipo) 28.00 32.34 66 75 2.72 4.05 52 59
Periplasmic 19.86 18.25 105 133 2.2 2.28 90 127
Total predicted outer membrane/periplasmic 95.70 98.71 204 247 8.29 11.37 164 219
Cytoplasmic
Ribosomal 0.86 0.28 43 35 15.03 15.08 53 53
Other cytoplasmic 0.63 0.20 177 93 65.08 61.30 1137 1198
Cytoplasmic membrane
Tail-speciﬁc protease 1.15 0.21 1 1 0.03 0.02 1 1
Other cytoplasmic membrane 0.24 0.13 53 29 7.00 6.44 291 346
Extracellular 0.00 – 1 0 0.02 0.01 5 4
Unknown
YajG 1.28 0.34 1 1 0.04 0.05 1 1
Other unknown 0.13 0.13 35 28 4.51 5.72 216 245
Total predicted non-OM/periplasmic 4.30 1.29 311 187 91.71 88.63 1704 1848
Table 2
40 most abundant proteins found in GMMA (by average % mass in Sf2a and Ss GMMA).
Gene name Location Protein name Uniprot name Average % mass
in GMMA
% mass in Sf2a
GMMA
% mass in Ss
GMMA
SF2457T 0298 OM Outer membrane protein C E3XX60 SHIFL 13.411 14.619 12.203
SF2457T 0799 OM Outer membrane protein A E3XYK2 SHIFL 11.943 10.615 13.271
SS53G 3941 OM Outer membrane protein X E9UMG3 SHISO 8.506 11.829 5.183
SS53G 0415 OM lipo Repeated sequence found in lipoLPP family prot. E7JU63 SHISO 7.261 9.955 4.566
SF2457T 4977 PP Protease Do (HtrA) E3YA49 SHIFL 4.604 7.366 1.842
SS53G 2965 OM lipo Entericidin B E7K193 SHISO 4.257 0.101 8.413
SS53G 0370 OM lipo Outer membrane lipoprotein pcp E7JU20 SHISO 3.528 4.570 2.485
tolB PP Protein tolB TOLB SHISS 2.859 2.637 3.080
SS53G 0760 OM Outer membrane porin protein LC E7JV54 SHISO 2.419 0.479 4.358
SF2457T 3748 OM Outer membrane protein E3Y6Q5 SHIFL 2.145 2.654 1.636
yaeT OM Outer membrane protein assembly factor yaeT YAET SHISS 1.646 2.258 1.035
lpoA OM lipo Penicillin-binding protein activator LpoA LPOA SHIF8 1.595 1.679 1.510
SF2457T 0832 OM Outer membrane protein F E3XYN5 SHIFL 1.471 1.036 1.905
SGF 01778 OM lipo Glycoprotein-polysaccharide metabolism E7TB57 SHIFL 1.465 0.280 2.650
SS53G 1454 OM lipo Osmotically inducible lipoprotein B E7JX36 SHISO 1.256 1.692 0.820
lamB OM Maltoporin LAMB SHISS 1.156 0 2.312
slp OM lipo OM protein induced after carbon starvation Q3YWI0 SHISS 1.151 0.014 2.288
SGF 00427 OM Aerobactin siderophore receptor IutA E7T7F9 SHIFL 0.977 1.486 0.468
SF2457T 4357 PP Peptidyl-prolyl cis-trans isomerase E3Y8E7 SHIFL 0.932 0.968 0.896
pal OM lipo Peptidoglycan-associated lipoprotein E7K8X6 SHISO 0.873 0.930 0.816
SS53G 1748 PP Putative uncharacterized protein E7JXX8 SHISO 0.869 1.080 0.658
SS53G 0544 OM lipo SmpA/OmlA family protein E7JUJ2 SHISO 0.829 0.170 1.489
yajG Unknown Putative polymerase/proteinase Q3Z4W9 SHISS 0.808 1.276 0.340
SF2457T 2094 PP Periplasmic oligopeptide-binding protein E3Y260 SHIFL 0.769 1.065 0.473
SF2457T 2279 CytoM Tail-speciﬁc protease E3Y2N8 SHIFL 0.679 1.152 0.206
surA PP Chaperone surA SURA SHISS 0.623 0.787 0.458
SF2457T 0435 OM Long-chain fatty acid outer membrane transporter E3XXF4 SHIFL 0.622 0.062 1.181
SS53G 1935 OM lipo SmpA/OmlA family protein E7JYG3 SHISO 0.611 0.858 0.364
degQ PP Serine endoprotease Q3YX14 SHISS 0.592 0.053 1.132
SS53G 3947 PP Putative uncharacterized protein E9UMG9 SHISO 0.540 0.816 0.265
SF2457T 3200 OM lipo Pectinesterase B E3Y553 SHIFL 0.532 0.651 0.414
SF2457T 3582 OM lipo Peptidase family M48 family protein E3Y5Y2 SHIFL 0.530 0.555 0.504
livJ PP High-afﬁnity amino acid transport system Q3YW68 SHISS 0.521 0.264 0.777
yeaF OM Putative uncharacterized protein yeaF Q3Z2C1 SHISS 0.507 0.479 0.535
SS53G 4569 OM lipo Putative phospholipid-binding domain protein E7K576 SHISO 0.468 0.535 0.401
SF2457T 4988 OM Ferrichrome-iron receptor E3YA60 SHIFL 0.435 0.816 0.053
SF2457T 4129 PP PP dipeptide transport protein E3Y7S0 SHIFL 0.434 0.401 0.467
t
0
b
m
iybjP OM lipo Putative enzyme
SF2457T 3629 OM Serine protease eatA
yfgL OM-Lipo Outer membrane assembly lipoprotein YfgL
o the identity line and the Pearson correlation coefﬁcients were
.80 and 0.91 for GMMA and lysates, respectively (p<0.0001 for
oth).
There were a small number of proteins that were relatively
ore abundant in the Ss GMMA than in the Sf2a GMMA, includ-
ng some proteins of moderate abundance that were only seen inQ0T8Q3 SHIF8 0.414 0.429 0.400
E3Y628 SHIFL 0.410 0.115 0.705
E7JUN3 SHISO 0.409 0.571 0.246
the Ss GMMA (Table 3). Approximately half of these proteins were
conﬁrmed to be absent in Sf2a by genome analysis (Table 3). In
contrast, therewereonly4moderately abundantproteinswithpre-
dicted outer membrane or periplasmic localization in Sf2a GMMA
that were not found in Ss GMMA of which by genome analysis only
1 protein would be expected to be present in Sf2a (Table 4).
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Fig. 1. The relative abundance of proteins identiﬁed in GMMA compared to their abundance in whole cell lysates. (A) S. ﬂexneri 2a and (B) S. sonnei. Proteins are plotted
according to the percent of the estimated protein mass in the two samples and color coded according to the predicted location as follows: light orange, outer membrane
lipoprotein; dark orange, integral outer membrane proteins; dark red, periplasmic protein; dark blue, extracellular; olive green, cytoplasmic membrane; yellow, cytoplasmic.
Ribosomal proteins are distinguished from other cytoplasmic proteins by the green bar. Only proteins identiﬁed in GMMA are plotted. Proteins detected in GMMA but not in
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ysate, respectively. (For interpretation of the references to color in the ﬁgure legen
For proteins detected both in Sf2a and Ss we assessed the repro-
ucibility of protein abundance in the Sf2a and Ss Lysate based on
he log ratio of iBAQ. Considering the common 1696 proteins, the
istribution of the log ratios closely followed a normal distribution
ith a best ﬁt (minimized sum of errors squared) mean of 0.0054
ith SD of 0.42 (Fig. S1A). Thus, for the 1696 proteins the average
orrelation of the %masswas 1.01 (antilog of 0.0054). The impact of
hemagnitude of the iBAQ on themean and SD of the log ratioswas
ested by dividing the protein population into 10 groups of increas-
ng iBAQ. No variation in the log ratio or SDwas seen in groupswith
eometricmean iBAQ ranging from10,000 to 10,000,000 (Fig. S1B).
his is consistentwith the individual abundance plots in Fig. 2B and
revious studies using iBAQ (Schwanhäusser et al., 2011). There
as a small deviation with approximately 4.5% of Ss proteins with
ig. 2. The relative abundance of proteins identiﬁed in Ss GMMA compared to Sf2a GMMA
n the legend for Fig. 1, except ribosomal proteins are not explicitly marked but are par
train were assigned 0.000001% mass in the other strain and plotted on the axes. The lig
heoretical positions of proteins enriched 10-fold in Ss or 10-fold in Sf2a samples, respec
s referred to the web version of this article.)ly abundant in the GMMA and Lysate would be expected to lie on the dark diagonal
g the theoretical positions of proteins enriched 10-fold in GMMA or 10-fold in the
reader is referred to the web version of this article.)
an average of 10× greater abundance that the corresponding Sf2a
proteins (Fig. S1A and Table S1), similar to the ﬁndings in GMMA
(Table 3).
We investigated the technical reproducibility by measuring the
log ratio of iBAQ and corresponding SD for pairs of ribosomal pro-
teins in the two lysate samples. We assume that all ribosomes have
stoichiometric amounts of each protein and also that there is negli-
gible amountsof ribosomalproteinnot in ribosomes. Thusvariation
in the ratio of the iBAQ for the 53 pairs of ribosomal proteins in
the two lysates is a measure of the technical reproducibility of the
methods (Table S2). The ratio ofmolar abundance of ribosomal pro-
teins in the 2 samples had on average, a ratio of 1.11. Thus the ratio
of ribosomal proteins in the two samples was similar to the ratios
of all proteins (1.11 vs 1.01), but the standard deviation of the log
(A) and in Ss Lysate compared to Sf2a Lysates (B). The color codes are as described
t of the cytoplasmic proteins. Proteins detected in GMMA or Lysates from only 1
ht diagonal lines above and below the identity line are guidance lines marking the
tively. (For interpretation of the references to color in the ﬁgure legend, the reader
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Table 3
Proteins preferentially found in Ss GMMA.
Gene name Location Protein name Uniprot name % mass in Ss GMMA Ratio Theoretically
present in Sf2a*
Predicted outer membrane and periplasmic localized proteins with at least 0.01% mass in Ss GMMA not found in Sf2a GMMA
SS53G 2461 PP Maltose-binding periplasmic protein E7JZV4 SHISO 0.799 −** +
SS53G 0290 OM lipo TonB-dependent Receptor Plug domain protein E7JTU0 SHISO 0.732 − −
SS53G 3463 OM Iron(III) dicitrate transport protein fecA E7K2N5 SHISO 0.589 − −
cirA OM OM receptor for iron-regulated colicin I receptor Q3Z051 SHISS 0.430 − −
exc OM lipo Entry exclusion protein 2 A4SH43 SHISS 0.423 − −
SS53G 3761 OM Ferrichrome-iron receptor E7K3K6 SHISO 0.396 − −
SS53G 2464 PP Maltose operon periplasmic protein E7JZV7 SHISO 0.337 − +
ycdO PP UPF0409 protein ycdO YCDO SHISS 0.276 − +
SS53G 0127 OM Putative tonB-dependent receptor yncD E7JTC8 SHISO 0.159 − −
hdeA PP Putative uncharacterized protein hdeA Q3YWI4 SHISS 0.140 − +
mdoG PP Glucans biosynthesis protein G OPGG SHISS 0.106 − +
SS53G 2146 PP Putative uncharacterized protein E7JZ10 SHISO 0.064 − −
SS53G 0128 PP PQQ enzyme repeat family protein E7JTC9 SHISO 0.058 − −
SS53G 5268 OM TonB-dependent Receptor Plug domain protein E7K7A5 SHISO 0.053 − +
SS53G 2796 OM lipo Inner membrane lipoprotein yiaD E7K0S5 SHISO 0.051 − +
SSON 1625 PP Putative sulfatase Q3Z1P2 SHISS 0.047 − −
SS53G 0368 OM lipo Putative uncharacterized protein E7JU18 SHISO 0.036 − −
SS53G 4157 PP Putative uncharacterized protein E7K461 SHISO 0.032 − +
yehZ PP Putative transport system permease protein Q3Z073 SHISS 0.026 − +
SS53G 4973 PP Acid-resistance protein E7K6I7 SHISO 0.025 − +
SS53G 0106 PP Bacterial extracellular solute-binding family protein E7JTA7 SHISO 0.024 − −
SSON 1637 PP Putative hemin-binding lipoprotein Q3Z1N0 SHISS 0.022 − −
tauA PP Taurine transport system periplasmic protein Q3Z543 SHISS 0.019 − −
SS53G 3203 OM lipo Putative uncharacterized protein E7K1X5 SHISO 0.015 − +
Predicted outer membrane and periplasmic localized proteins highly enriched in Ss GMMA compared to Sf2a GMMA***
lamB OM Maltoporin LAMB SHISS 2.312 6017
slp OM lipo Outer membrane protein induced after carbon starvation Q3YWI0 SHISS 2.288 163
glpQ PP Glycerophosphodiester phosphodiesterase, periplasmic Q3YZW7 SHISS 0.609 193
SS53G 4155 OM lipo Putative polysaccharide export protein gfcE E7K459 SHISO 0.313 170
SS53G 3546 PP Putative phospholipid-binding domain protein E7K2W6 SHISO 0.249 321
SS53G 4156 OM Putative uncharacterized protein E7K460 SHISO 0.216 239
SS53G 5756 PP Glutamate/aspartate periplasmic-binding protein E7K8P1 SHISO 0.105 230
ycdB PP Peroxidase ycdB (Deferrochelatase/peroxidase EfeB) YCDB SHISS 0.091 246
ymcC OM lipo Putative regulator Q3Z3D5 SHISS 0.052 376
blc OM lipo Outer membrane lipoprotein Q3YUI9 SHISS 0.051 329
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P* Present if protein sequence with ≥90% coverage and ≥95% identity was identiﬁ
** Protein not detected in Sf2a GMMA.
*** Proteins >0.01% total protein mass and with at least 100× higher % mass in Ss G
atio was lower for the ribosomal proteins compared to all proteins
0.22 vs 0.42).
The accuracy of using iBAQ to estimate the molar concentra-
ion of proteins was assessed by comparing the iBAQ values of
he individual ribosomal proteins within each lysate (Table S2),
gain assuming a negligible amount of free ribosomal proteins, as
ibosomal proteins should be present in the same molar quantity
egardless of the size variation. Similar to other studies (Arike et al.,
012), there was appreciable variation in the molar estimates with
he 95% conﬁdence interval calculated from the log transformed
BAQ covering a 10.7- and 8.5-fold range for the Sf2a and Ss lysates,
espectively.
Since we were able to show that most proteins are present in
pproximately equal relative quantities in the Ss and Sf2a Lysates,
e used the frequency at which the orthologs were detected in
oth the Ss and Sf2a Lysates to estimate detection limit of this
ssay. First, for each protein that was detected only in either the
able 4
roteins preferentially found in Sf2a GMMA.
Gene name Location Protein name Un
Predicted outer membrane and periplasmic localized proteins with at least 0.01% m
SF2457T 1008 OM lipo Uncharacterized lipoprotein ydcL E3
SF2457T 0155 OM lipo Lipoprotein E3
sitA PP Iron transport protein Q3
SF2457T 3658 OM Antigen 43 E3
* Present if protein sequence with ≥90% coverage and ≥95% identity was identiﬁed in Sf2a proteome or translated genome.
than Sf2a GMMA.
Ss or the Sf2a Lysates, we checked if the gene was present in both
genomes and was likely to be functional (i.e. absence of frame shift
mutations). This resulted in 2017 proteins where at least one was
detected and both Ss and Sf2a potentially had functional genes.
We ranked the proteins in order of increasing individual iBAQ or
average iBAQ (where bothwhere present), and then divided the set
into 40 groups of increasing iBAQ. We counted the percentage of
cases where proteins were detected in both samples (conditional
on detecting at least one) and plotted this against the mean iBAQ of
the group (Fig. S2). We assumed that the probability (p) of detect-
ing a protein in a single sample was a simple hyperbolic function
of iBAQ (p= iBAQ/(iBAQ+ iBAQ0.5), where iBAQ0.5 is the iBAQ
with a 50% probability of detection. We then did an unweighted
ﬁt of the percentage of cases where proteins were detected in
both samples (% two proteins detected=100p2/(2(1−p)p+p2) to
iBAQ, minimizing the sum of error squared. This gave a good ﬁt
(r2 =0.754) with an iBAQ0.5 of 6134.
iprot name % mass in Sf2a GMMA Theoretically present in Ss*
ass in Sf2a GMMA not found in Ss GMMA
XZ64 SHIFL 0.035 −
XWR9 SHIFL 0.035 −
Z1C5 SHISS 0.024 +
Y656 SHIFL 0.014 −
s proteome or translated genome.
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. Discussion
In previous studies that identiﬁed proteins in outer membrane
lebs (SOMV, NOMV and GMMA), proteins with predicted outer
embrane or periplasmic localization accounted for half or fewer
f all identiﬁed proteins (Berlanda Scorza et al., 2008, 2012; Choi
t al., 2011; Lappann et al., 2013; Mullaney et al., 2009; Park et al.,
011; Pierson et al., 2011; Roier et al., 2015; van de Waterbeemd
t al., 2013; Zybailov et al., 2006). In the study presented here, we
lso found less than half of all proteins to have predicted outer
embrane or periplasmic localization, with 265 of 659 proteins
dentiﬁed in either Sf2a or Ss GMMA. Analyzing the protein con-
ent quantitatively gives a different view. As measured by iBAQ,
early all of the protein content in the GMMA is predicted to be
erived from outer membrane or periplasmic localized proteins:
n this study 95.7% and 98.7% of the protein content in Sf2a and Ss
MMA, respectively.
The most abundant outer membrane proteins in the GMMA
ere identiﬁed as OmpA, OmpC, and OmpX consistent with pre-
ious observations with Ss GMMA (Berlanda Scorza et al., 2012)
ndwith the preparation of GMMA from cultures in the early expo-
ential phase (Zhu et al., 2007). Surprisingly, Entericidin B and not
pp (Braun, 1975), the most abundant lipoprotein in E. coli, was the
ost abundant lipoprotein in Ss GMMA (8.4%) while it comprised
nly 0.1% mass in Sf2a GMMA. This difference could be related to
he difference in the media composition.
A total of 60 samples (15 gel slices of each of the 4 preparations,
ig. S3) were used in this study and the large number of sam-
lesmade technical or biological replicates problematic. Therefore,
he estimates of the reliability of the study relies on the consis-
ency between the Sf2a and Ss GMMA samples, between the Sf2a
nd Ss Lysate samples and between the corresponding GMMA and
ysate samples. Several measures of the reproducibility and preci-
ion were included in the analysis.
Estimates of the relative mass of the proteins depends on the
ssumption that iBAQ is a useful measure of the relative molar
uantities of the proteins present. Analysis of the iBAQ values of
ibosomal proteins within a sample provides an estimate of the
ccuracy in this study: the calculated molar ratios varied with a
5% conﬁdence interval of approximately 9.6-fold (Table S2) in line
ith other studies (Arike et al., 2012; Maier et al., 2011; Ishihama
t al., 2008). Although the uncertainty of individual protein abun-
ances is relatively large, when averaged over large numbers of
roteins the error in the estimate, e.g. of cytoplasmic contamina-
ion in GMMA, will be small. Comparison of the ribosomal data
etween the Sf2a and Ss samples showed that the reproducibil-
ty between samples is good. The variance of the log ratios of the
ibosomal proteins was 0.049 (i.e. 95% conﬁdence interval of 2.7-
old) but the variance of the 1696 common proteins in the lysate
as 0.17. This suggests that approximately a quarter of the varia-
ion between the samples from Sf2a and Ss results from variation
ithin the method, e.g. sample preparation or the mass spectrom-
try, whereas three quarters of the variance is a true difference
etween the Sf2a and Ss Lysates, reﬂecting differential abundance
f speciﬁc proteins.
There are two groups of proteins where the reproducibility
etween samples was much less than expected: 4.5% of proteins
ere approximately 10× overexpressed in Ss compared to Sf2a.
n addition, 11 of the 191 protein present in the Ss GMMA at an
bundance of >0.01% were not detected in Sf2a despite the corre-
pondinggenebeingpresent inSf2aand10of the191proteinswere
100 times more abundant than in Sf2a GMMA. In contrast, only
protein present in Sf2a GMMA at >0.01% of total protein was not
etected in Ss GMMA though the gene is present (Tables 3 and 4).
he iBAQ score in the Ss or Sf2a GMMA for the proteins absent in
MMA from the other strain ranged from 326,930 to 10,197,000.dical Microbiology 306 (2016) 99–108
If the detection limit for the GMMA samples was similar to that
assessed on the Lysate, the corresponding probability of detecting
these proteins ranged from 0.965 to 0.999. Therefore, it is unlikely
that these were present at a similar abundance and missed by
chance. Of the proteins that were highly enriched in Ss GMMA
compared to Sf2a GMMA, 3 are related to maltose metabolism:
maltose-binding periplasmic protein (E7JZV4 SHISO), a homo-
logue of MalE (Chapon, 1982), maltose operon periplasmic protein
(E7JZV7 SHISO), a homologue of MalM (Gilson et al., 1986), and
maltoporin LamB (LAMB SHISS). The corresponding genes are part
of the malT operon and subject to catabolite repression (Chapon,
1982) and thus the addition of glucose to the growth medium
for Sf2a but not for Ss is a possible reason for the low or absent
expression of these three genes. For the other proteins, the reason
for the relative abundance in Ss is unclear.
Since the lysates are solubilized whole cells, all the proteins
found in GMMA should also be in the lysates, albeit at lower rela-
tive abundance. Comparison of the Sf2aGMMAwith the Sf2a Lysate
and Ss GMMA with the Ss Lysate (Fig. 1) conﬁrmed this assump-
tion and demonstrated that most of the proteins detected in the
GMMA samples were also present in the lysates at approximately
the same abundance ranks. Moreover, comparison of Sf2a Lysate
with Ss Lysate showed that most of the proteins were conserved in
the samples from the two strains and that on average were present
at the same abundance (Fig. 2B). Similarly, the common proteins in
Sf2a GMMA with Ss GMMA accounting for 99.6% and 94.9% of the
protein mass, respectively, were present in close to the same mass
rank order.
In both the Sf2a and Ss GMMA, approximately 20% of the pro-
tein was predicted to be periplasmic. This was twice the value
for outer membrane blebs from P. aeruginosa (10% (Choi et al.,
2011)) and three times that for N. meningitidis (6.2% (Lappann
et al., 2013)) suggesting that the Pseudomonas NOMV and Neis-
seria SOMV had a larger surface to volume ratio than the Shigella
GMMA in this study. A surprising observation in the current study
was the approximately 10-fold enrichment of both periplasmic and
outer membrane proteins in GMMA compared to total cell pro-
teins (Fig. 1A and B). This suggests that the GMMA co-incidentally
have a similar surface to volume ratio as the surface to periplasmic
volume ratio of the bacteria. Electron microscopy of hyperbleb-
bing bacteria with the tolR mutation showed that the separation
between inner and outer membrane is substantially greater than
in the wild-type bacteria (Meloni E, unpublished data). Thus, the
genetic enhancement bleb formation may be linked to the enrich-
ment of periplasmic proteins in Sf2a and Ss GMMA (approximately
20% in both) compared to spontaneously released vesicles from
P. aeruginosa (10% (Choi et al., 2011)) and N. meningitidis (6.2%
(Lappann et al., 2013)).
The “purity” of the GMMA with respect to outer membrane
and periplasmic proteins is likely to be even higher than the ini-
tial analysis suggested: Two proteins, Tail-speciﬁc protease and
YajG, highly enriched in GMMAbut not predicted to be outermem-
brane or periplasmic proteins (Fig. 1) appear to be misclassiﬁed
using the sequences from the Shigella database. Tail-speciﬁc pro-
tease is known to be a soluble periplasmic protease in E. coli (Keiler
and Sauer, 1996) and the YajG homologue in E. coli is a lipopro-
tein with a classic LIPO box (Boudet et al., 2007). Taking this into
account, 98.1% and 99.3% of Sf2a and Ss GMMA, respectively, would
be periplasmic or outer membrane localized proteins. Much of the
remaining protein content is ribosomal proteins. The GMMA used
in this study were puriﬁed by ultracentrifugation under conditions
that contaminating ribosomes, if present in the medium as a result
of low-level bacterial lysis, are likely to have been co-sedimented
with the GMMA. It will be interesting to see if GMMA puriﬁed
using ﬁltration, for use in vaccines are also contaminated with
ribosomes.
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These results are different to the data from naturally shed outer
embrane vesicles fromN. meningitidiswhere 85.8% of the protein
ass in the SOMV was predicted to be periplasmic (6.2%) or outer
embrane (79.6%) (Lappann et al., 2013). For P. aeruginosa NOMV
he prediction was even lower with approximately 47% of the pro-
ein in the vesicles predicted to be periplasmic or outer membrane
Choi et al., 2011). Importantly, the cytoplasmic and inner mem-
rane predicted proteins thatwould be considered impurities in an
uter membrane bleb-based vaccine accounted for 13.9% inNeisse-
ia SOMV (Lappann et al., 2013) or 38% in PseudomonasNOVM(Choi
t al., 2011) in contrast to 4.4% in Sf2a GMMA and only 1.3% in Ss
MMA (or only 1.9% and 0.7%, respectively, assuming misclassiﬁ-
ation of Tail-speciﬁc protease and YajG).
It is unlikely that these differences relate to differences in the
urface polysaccharide content or LPS/LOS structure: The Pseu-
omonaswaspresumably encapsulated (not speciﬁed in thepaper),
ut the Neisseria had the capsule deleted and neither Shigella lines
ere encapsulated (Caboni et al., 2015). By deleting the O antigen,
he LPS of the Shigella lines had a similar size and structure to the
OS present in the Neisseria. The Pseudomonas and the Shigella had
wild type Lipid A component of their LPS, the Neisseria contained
he lpxL mutation that results in penta-acylated lipid A. It is pos-
ible that the differences observed in these studies relates to the
se of the tolR mutation in Shigella that result in a very high levels
f blebbing. By substantially increasing the production of GMMA,
he level of impurities in the resulting GMMA preparation is likely
o be substantially reduced. This is a critical point for vaccine pro-
uction: it suggests that cytoplasmic proteins are not intrinsically
ound to GMMA and therefore their presence needs to be carefully
ontrolled.
In conclusion, using quantitative proteomics, we show that we
an produce GMMA from S. sonnei and S. ﬂexneri 2a that contain the
xpected outer membrane and periplasmic proteins and have the
ow levels of cytoplasmic protein contamination. This makes their
omposition and purity suitable for vaccines.
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